Mauskopf J, Chirila C, Birt J, Boye KS, Bowman L. Drug reimbursement recommendations by the National Institute for Health and Clinical Excellence: have they impacted the National Health Service budget? Health Policy (New York). 2013 Apr 1;110(1):49-59.
Mangel AW, Williams VSL. Asimadoline in the treatment of irritable bowel syndrome. Expert Opin Investig Drugs. 2010 Oct 1;19(10):1257-64.
Richter A, Hicks KA, Earnshaw SR, Honeycutt AA. Allocating HIV prevention resources: a tool for state and local decision making. Health Policy (New York). 2008 Sep 1;87(3):342-9.
Lovas K, Kalo Z, McKenna SP, Whalley D, Pentek M, Genti G. Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary. Health Policy (New York). 2003 Jan 1;63(1):20.
McKenna SP, Whalley D. Assessment of biotechnology drugs: what are the issues? Letter to the editor. Health Policy (New York). 1999 Nov;49(3):195-7. doi: 10.1016/S0168-8510(99)00055-X
Grubb NR, Sutherland GR, Campanella C, Fleming A, Sinclair CJ, Fox KA. Latissimus dorsi muscle: assessment of stimulation after cardiomyoplasty with Doppler US tissue imaging. Radiology. 1996 Apr 1;199(1):59-64. doi: 10.1148/radiology.199.1.8633173
Grubb NR, Fleming A, Sutherland GR, Fox KA. Skeletal muscle contraction in healthy volunteers: assessment with Doppler tissue imaging. Radiology. 1995 Mar 1;194(3):837-42. doi: 10.1148/radiology.194.3.7862989